| NCT04596865
| Recurrence After Whipple's (RAW) Study | No drug interventions | Not Available | Not Available | completed |
| NCT06644846
| Spatially Fractionated Radiation Treatment for Gynaecological Cancers | No drug interventions | treatment | Not Available | not_yet_recruiting |
| NCT05958121
| IMA402 T Cell-Engaging Receptor Molecule (TCER®) in Recurrent and/or Refractory Solid Tumors | No drug interventions | treatment | 1 / 2 | recruiting |
| NCT06208657
| Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer | | treatment | 1 / 2 | recruiting |
| NCT04784221
| Nanoparticles and Hypofractionated Protontherapy for Reirradiation of Pantumor Relapse | No drug interventions | treatment | 2 | not_yet_recruiting |
| NCT02410187
| SBRT for Extra-cranial Oligorecurrent Tumor | No drug interventions | treatment | 2 | unknown_status |
| NCT05359445
| IMA401 TCER® in Recurrent and/or Refractory Solid Tumors | No drug interventions | treatment | 1 | recruiting |
| NCT05364905
| Patients Characteristics, Treatment Pattern & Outcomes of Patients With Advanced, Recurrent or Metastatic Endometrial Carcinoma | No drug interventions | Not Available | Not Available | completed |
| NCT05855811
| PREventing Second Cancers With DOSTARlimab | | prevention | 2 | recruiting |
| NCT03441100
| TCR-engineered T Cells in Solid Tumors: IMA202-101 | No drug interventions | treatment | 1 | completed |
| NCT04889742
| Hyperthermia Enhanced Re-irradiation of Loco-regional Recurrent Tumors | No drug interventions | treatment | 2 | not_yet_recruiting |
| NCT06103617
| Safety and Superiority of Penicillamine in Radiosensitization of Recurrent Head and Neck Cancer | | treatment | 2 | recruiting |
| NCT05990920
| Study of Allogeneic Blood-derived Natural Killer Cells to Evaluate Safety and Tolerability in Cancer Refractory to Conventional Therapy | No drug interventions | treatment | 1 | active_not_recruiting |
| NCT04421560
| Pembrolizumab, Ibrutinib and Rituximab in PCNSL | | treatment | 1 / 2 | recruiting |
| NCT05045040
| Empathetic Communication Facilitation Program for Early Initiation of End-of-life Discussions | No drug interventions | supportive_care | Not Available | recruiting |
| NCT05002140
| Trial of XRD-0394, a Kinase Inhibitor, in Combination With Palliative Radiotherapy in Advanced Cancer Patients | No drug interventions | treatment | 1 | completed |
| NCT03758781
| IRX-2 Regimen Combined With Nivolumab in Recurrent/Metastatic Solid Tumors | | treatment | 1 | completed |
| NCT05200195
| Deep Learning Model for the Prediction of Post-LT HCC Recurrence | No drug interventions | Not Available | Not Available | completed |
| NCT05189054
| Safety and Efficacy of SBRT in the Reirradiation for Ultra-central Thoracic Malignant Tumors | No drug interventions | Not Available | Not Available | recruiting |
| NCT04326088
| Postoperative Complication After Free Flap Reconstruction for Head and Neck Cancer | No drug interventions | Not Available | Not Available | completed |
| NCT03760952
| Human Leukocyte Antigen Typing and Tumor Antigen Expression Profiling | No drug interventions | Not Available | Not Available | completed |
| NCT05396300
| A Clinical Study of CEA-targeted CAR-T in the Treatment of CEA-positive Advanced Malignant Solid Tumors | No drug interventions | treatment | 1 | recruiting |
| NCT05415475
| Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced Malignant Solid Tumors | No drug interventions | treatment | 1 | recruiting |
| NCT03686124
| ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors | | treatment | 1 | recruiting |
| NCT05043922
| A Study to Evaluate the Efficacy and Safety of CYH33 in Patients With Recurrent/Persistent Ovary Clear Cell Carcinoma | No drug interventions | treatment | 2 | unknown_status |
| NCT06372574
| A Study of RO7617991 in Patients With Locally Advanced or Metastatic MAGE-A4-Positive Solid Tumors | | treatment | 1 | withdrawn |
| NCT05250791
| Feasibility Study of Lidocaine Infusion During Bowel Cancer Surgery for Cancer Outcome | | treatment | Not Available | recruiting |
| NCT03941262
| Safety of SNK01 in Subjects With Pathologically Confirmed Metastatic and/or Unresectable Cancer Refractory to Conventional Therapy | | treatment | 1 | completed |
| NCT05626829
| Tranilast as a Radiosensitizer in Reradiation of Nasopharyngeal Carcinoma | | treatment | 2 | recruiting |
| NCT04204850
| Cabozantinib to Treat Recurrent Liver Cancer Post Transplant | | treatment | 2 | recruiting |
| NCT03132038
| Nivolumab in Recurrent or Metastatic Salivary Gland Carcinoma of the Head and Neck | | treatment | 2 | completed |